Wealthcare Advisory Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.41M | Sell |
3,162
-29
| -0.9% | -$12.9K | 0.03% | 409 |
|
2025
Q1 | $1.55M | Sell |
3,191
-70
| -2% | -$33.9K | 0.04% | 350 |
|
2024
Q4 | $1.31M | Buy |
3,261
+172
| +6% | +$69.3K | 0.04% | 365 |
|
2024
Q3 | $1.44M | Sell |
3,089
-239
| -7% | -$111K | 0.04% | 332 |
|
2024
Q2 | $1.56M | Buy |
3,328
+110
| +3% | +$51.6K | 0.05% | 285 |
|
2024
Q1 | $1.35M | Buy |
3,218
+141
| +5% | +$58.9K | 0.04% | 304 |
|
2023
Q4 | $1.25M | Sell |
3,077
-41
| -1% | -$16.7K | 0.05% | 271 |
|
2023
Q3 | $1.08M | Sell |
3,118
-33
| -1% | -$11.5K | 0.05% | 264 |
|
2023
Q2 | $1.11M | Sell |
3,151
-208
| -6% | -$73.2K | 0.05% | 267 |
|
2023
Q1 | $1.06M | Sell |
3,359
-91
| -3% | -$28.7K | 0.05% | 279 |
|
2022
Q4 | $996K | Buy |
3,450
+91
| +3% | +$26.3K | 0.05% | 276 |
|
2022
Q3 | $973K | Buy |
3,359
+156
| +5% | +$45.2K | 0.06% | 242 |
|
2022
Q2 | $903K | Sell |
3,203
-281
| -8% | -$79.2K | 0.05% | 221 |
|
2022
Q1 | $909K | Sell |
3,484
-141
| -4% | -$36.8K | 0.06% | 210 |
|
2021
Q4 | $796K | Buy |
3,625
+2,185
| +152% | +$480K | 0.05% | 232 |
|
2021
Q3 | $261K | Buy |
1,440
+6
| +0.4% | +$1.09K | 0.02% | 455 |
|
2021
Q2 | $289K | Buy |
1,434
+33
| +2% | +$6.65K | 0.02% | 436 |
|
2021
Q1 | $301K | Buy |
+1,401
| New | +$301K | 0.02% | 395 |
|
2020
Q2 | – | Sell |
-107
| Closed | -$25K | – | 1336 |
|
2020
Q1 | $25K | Buy |
107
+4
| +4% | +$935 | ﹤0.01% | 680 |
|
2019
Q4 | $23K | Hold |
103
| – | – | ﹤0.01% | 736 |
|
2019
Q3 | $17K | Hold |
103
| – | – | ﹤0.01% | 797 |
|
2019
Q2 | $19K | Hold |
103
| – | – | ﹤0.01% | 739 |
|
2019
Q1 | $19K | Hold |
103
| – | – | ﹤0.01% | 677 |
|
2018
Q4 | $17K | Hold |
103
| – | – | ﹤0.01% | 669 |
|
2018
Q3 | $20K | Hold |
103
| – | – | ﹤0.01% | 679 |
|
2018
Q2 | $18K | Hold |
103
| – | – | ﹤0.01% | 702 |
|
2018
Q1 | $17K | Sell |
103
-3
| -3% | -$495 | ﹤0.01% | 626 |
|
2017
Q4 | $16K | Buy |
106
+3
| +3% | +$453 | ﹤0.01% | 581 |
|
2017
Q3 | $16K | Buy |
+103
| New | +$16K | ﹤0.01% | 466 |
|